On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

COL11A2

collagen type XI alpha 2 chain

The COL11A2 gene provides instructions for making a crucial component of type XI collagen, essential for the structure and strength of connective tissues, particularly cartilage, bone, and the inner ear. COL11A2 encodes the pro-alpha2(XI) chain of type XI collagen, a protein vital for supporting the body's tissues.

Chromosome 6p21.32 Autosomal recessive HGNC:2187 Tier C
COL11A2 6p21.32 p arm q arm 6

COL11A2 is located on the short (p) arm of chromosome 6, at band 6p21.32. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 6 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The COL11A2 gene, or collagen type XI alpha 2 chain, is fundamental for producing one of the three chains that form type XI collagen. This collagen type is a key structural component found in various connective tissues throughout the body, including cartilage, bone, and certain parts of the inner ear and spinal discs.

Type XI collagen contributes to the strength and structural integrity of these tissues. Variants in COL11A2 are associated with a spectrum of inherited conditions primarily affecting skeletal development and hearing.

What the gene does

The COL11A2 gene is responsible for synthesising the pro-alpha2(XI) chain, a subunit of type XI collagen. Collagens are fibrous proteins that provide structural support to connective tissues. The pro-alpha2(XI) chain combines with other collagen chains, specifically pro-alpha1(XI) and pro-alpha1(II), to form a triple-stranded procollagen molecule.

This procollagen then undergoes processing by enzymes to create mature collagen. These mature molecules assemble into long, thin fibrils, forming strong type XI collagen fibres in the extracellular matrix. Type XI collagen plays a role in regulating the spacing and diameter of type II collagen fibrils, which are critical for the normal structure of mature cartilage.

Video: Genetics 101

Chromosome location

The COL11A2 gene is situated on chromosome 6, specifically at band 6p21.32. This genomic location positions the gene within the short arm of chromosome 6.

Protein structure

The COL11A2 protein, which is 1736 amino acids long, contains several distinct functional regions and domains. Key domains include the Laminin G-like domain (amino acids 57-228) and multiple Collagen-like domains, such as Collagen-like 1 (amino acids 399-447), Collagen-like 2 (amino acids 487-545), Collagen-like 3 (amino acids 546-590), Collagen-like 4 (amino acids 805-862), Collagen-like 5 (amino acids 863-899), Collagen-like 6 (amino acids 1099-1156), Collagen-like 7 (amino acids 1157-1172), and Collagen-like 8 (amino acids 1441-1499). It also features several Nonhelical and Disordered regions, including a Triple-helical region (amino acids 487-1500), and a Fibrillar collagen NC1 domain (amino acids 1541-1735).

Domain map · 1,736 amino acids
Laminin G-like (57-228)Collagen-like 1 (399-447)Collagen-like 2 (487-545)Collagen-like 3 (546-590)Collagen-like 4 (805-862)Collagen-like 6 (1099-1156)Collagen-like 8 (1441-1499)Fibrillar collagen NC1 (1541-1735)Laminin G-like57-228Collagen-like 2487-545Fibrillar collagen NC11541-17351~8681,736
Domain - independent functional unit
🧬 Explore 3D structure on AlphaFold
UniProt:P13942Length:1,736 aaStructure:AlphaFold

Key variants

Variants within the COL11A2 gene can alter the structure or function of the pro-alpha2(XI) collagen chain, potentially disrupting the formation and stability of type XI collagen. Such changes can lead to a range of effects on connective tissues, particularly those rich in collagen, like cartilage and bone. These genetic changes are typically inherited in an autosomal recessive manner.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for COL11A2.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1019dup
Duplication
p.Pro340_Glu341insTer Pathogenic/Likely pathogenic ★★☆☆ not provided
c.1297C>T
single nucleotide variant
p.Arg433Ter Pathogenic/Likely pathogenic ★★☆☆ Otospondylomegaepiphyseal dysplasia, autosomal dominant
c.1606C>T
single nucleotide variant
p.Arg536Ter Pathogenic/Likely pathogenic ★★☆☆ not provided
c.1672C>T
single nucleotide variant
p.Arg558Ter Pathogenic ★★☆☆ Otospondylomegaepiphyseal dysplasia, autosomal recessive
c.181C>T
single nucleotide variant
p.Arg61Ter Pathogenic ★★☆☆ COL11A2-related disorder
c.2158C>T
single nucleotide variant
p.Arg720Ter Pathogenic/Likely pathogenic ★★☆☆ Monogenic hearing loss
c.2763del
Deletion
p.Gly922fs Pathogenic ★★☆☆ COL11A2-related disorder
c.3181C>T
single nucleotide variant
p.Arg1061Ter Pathogenic/Likely pathogenic ★★☆☆ COL11A2-related disorder
c.3329dup
Duplication
p.Gly1111fs Pathogenic/Likely pathogenic ★★☆☆ Fibrochondrogenesis 2
c.3545dup
Duplication
p.Gly1183fs Pathogenic/Likely pathogenic ★★☆☆ COL11A2-related disorder

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variants in the COL11A2 gene are associated with several inherited conditions, primarily affecting skeletal development and hearing. These include otospondylomegaepiphyseal dysplasia (OSMED), characterised by skeletal abnormalities, distinctive facial features, and severe hearing loss, and fibrochondrogenesis type 2, a severe disorder of bone growth. The gene is also implicated in some forms of Stickler syndrome and Weissenbacher-Zweymüller syndrome, which present with similar symptoms.

No disease links recorded for this gene in our reference set.

Inheritance pattern

Conditions caused by pathogenic COL11A2 variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous COL11A2 carrier status across ancestry groups?

UK clinical status

The COL11A2 gene is listed on several NHS Genomic Medicine Service clinical panels in the UK, indicating its importance in diagnostic testing for specific conditions. It is currently included on panels for Clefting, DDG2P, Foetal anomalies (R21), Monogenic hearing loss (R67), Skeletal dysplasia (R104), and Stickler syndrome (R45).

Frequently asked questions

What is the primary function of the COL11A2 gene?

The COL11A2 gene provides the instructions for making a component of type XI collagen. This collagen is vital for providing structure and strength to connective tissues, especially cartilage, bone, and parts of the inner ear and spinal discs.

What types of health conditions are associated with COL11A2 variants?

Variants in the COL11A2 gene are linked to several inherited conditions that primarily affect skeletal development and hearing. These include otospondylomegaepiphyseal dysplasia (OSMED), fibrochondrogenesis type 2, and certain forms of Stickler syndrome and Weissenbacher-Zweymüller syndrome.

How is COL11A2 typically inherited?

Conditions associated with variants in the COL11A2 gene are generally inherited in an autosomal recessive manner. This means an individual must inherit two copies of the altered gene, one from each parent, to develop the condition.

References

  1. Chakchouk I, Grati M, Bademci G. Novel mutations confirm that COL11A2 is responsible for autosomal recessive non-syndromic hearing loss DFNB53. Molecular genetics and genomics : MGG. 2015. PMID: 25633957
  2. Tompson SW, Faqeih EA, Ala-Kokko L. Dominant and recessive forms of fibrochondrogenesis resulting from mutations at a second locus, COL11A2. American journal of medical genetics. Part A. 2012. PMID: 22246659
  3. Ryder JJ, Garrison K, Song F. Genetic associations in peripheral joint osteoarthritis and spinal degenerative disease: a systematic review. Annals of the rheumatic diseases. 2008. PMID: 17720722
  4. Harel T, Rabinowitz R, Hendler N. COL11A2 mutation associated with autosomal recessive Weissenbacher-Zweymuller syndrome: molecular and clinical overlap with otospondylomegaepiphyseal dysplasia (OSMED). American journal of medical genetics. Part A. 2005. PMID: 15558753
  5. Jakkula E, Melkoniemi M, Kiviranta I. The role of sequence variations within the genes encoding collagen II, IX and XI in non-syndromic, early-onset osteoarthritis. Osteoarthritis and cartilage. 2005. PMID: 15922184
  6. Chen W, Kahrizi K, Meyer NC. Mutation of COL11A2 causes autosomal recessive non-syndromic hearing loss at the DFNB53 locus. Journal of medical genetics. 2005. PMID: 16033917
  7. De Leenheer EM, Kunst HH, McGuirt WT. Autosomal dominant inherited hearing impairment caused by a missense mutation in COL11A2 (DFNA13). Archives of otolaryngology--head & neck surgery. 2001. PMID: 11177008
  8. Melkoniemi M, Brunner HG, Manouvrier S. Autosomal recessive disorder otospondylomegaepiphyseal dysplasia is associated with loss-of-function mutations in the COL11A2 gene. American journal of human genetics. 2000. PMID: 10677296
  9. McGuirt WT, Prasad SD, Griffith AJ. Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nature genetics. 1999. PMID: 10581026
  10. Pihlajamaa T, Prockop DJ, Faber J. Heterozygous glycine substitution in the COL11A2 gene in the original patient with the Weissenbacher-Zweymüller syndrome demonstrates its identity with heterozygous OSMED (nonocular Stickler syndrome). American journal of medical genetics. 1998. PMID: 9805126
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .